Cargando…
Discovery of a Hydroxylamine-Based Brain-Penetrant EGFR Inhibitor for Metastatic Non-Small-Cell Lung Cancer
[Image: see text] Metastases to the brain remain a significant problem in lung cancer, as treatment by most small-molecule targeted therapies is severely limited by efflux transporters at the blood–brain barrier (BBB). Here, we report the discovery of a selective, orally bioavailable, epidermal grow...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Chemical Society
2023
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683025/ https://www.ncbi.nlm.nih.gov/pubmed/37934858 http://dx.doi.org/10.1021/acs.jmedchem.3c01669 |